FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 293:471-475 September 4, 1975 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Pneumonia caused by Pseudomonas aeruginosa occurs frequently in critically ill patients and is associated with a mortality rate of 70 per cent. An aerosol of polymyxin B was administered (2.5 mg per kilogram per day) to the upper airways of 292 patients in a respiratory-surgical intensive-care unit during a seven-month period, in an attempt to prevent Ps. aeruginosa pneumonia. Although only one of the patients studied acquired pneumonia due to Ps. aeruginosa, 10 others acquired pneumonia caused by a polymysinx-resistant organism. Seven pneumonias were caused by organisms not frequently pathogenic to man (flavobacteria, serratia and Streptococcus faecalis). The mortality rate for acquired pneumonia in this study, 64 per cent, is greater than that in previous studies in which either no polymyxin or cyclic polymyxin therapy was used. Continuous use of polymyxin B aerosol appears to be a dangerous form of therapy.

This article has been cited by other articles:

• Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
• Ioannidou, E., Siempos, I. I., Falagas, M. E. (2007). Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. J Antimicrob Chemother 60: 1216-1226 [Abstract] [Full Text]  
• Arnold, T. M., Forrest, G. N., Messmer, K. J. (2007). Polymyxin antibiotics for gram-negative infections. Am J Health Syst Pharm 64: 819-826 [Abstract] [Full Text]  
• Morar, P, Singh, V, Makura, Z, Jones, A S, Baines, P B, Selby, A, Sarginson, R, Hughes, J, van Saene, R (2002). Oropharyngeal carriage and lower airway colonisation/infection in 45 tracheotomised children. Thorax 57: 1015-1020 [Abstract] [Full Text]  
• Aarts, M.-A., Marshall, J. C. (2002). In Defense of Evidence: The Continuing Saga of Selective Decontamination of the Digestive Tract. Am. J. Respir. Crit. Care Med. 166: 1014-1015 [Full Text]  
• Chastre, J., Fagon, J.-Y. (2002). Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med. 165: 867-903 [Abstract] [Full Text]  
• Prober, C. G., Walson, P. D., Jones, J., the Committee on Infectious Diseases and Committee, (2000). Technical Report: Precautions Regarding the Use of Aerosolized Antibiotics. Pediatrics 106: 89e-89 [Abstract] [Full Text]  
• Campbell, P. W. III, Saiman, L. (1999). Use of Aerosolized Antibiotics in Patients With Cystic Fibrosis. Chest 116: 775-788 [Full Text]  
• Denton, M., Todd, N. J., Kerr, K. G., Hawkey, P. M., Littlewood, J. M. (1998). Molecular Epidemiology of Stenotrophomonas maltophilia Isolated from Clinical Specimens from Patients with Cystic Fibrosis and Associated Environmental Samples. J. Clin. Microbiol. 36: 1953-1958 [Abstract] [Full Text]  
• Denton, M., Kerr, K. G. (1998). Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 11: 57-80 [Abstract] [Full Text]